Ovid Therapeutics Inc

NASDAQ:OVID   12:58:29 PM EDT
3.27
-0.05 (-1.51%)
Earnings Announcements

Ovid Therapeutics Reports Q3 Loss Per Share Of $0.17

Published: 11/10/2021 18:23 GMT
Ovid Therapeutics Inc (OVID) - Ovid Therapeutics Inc - Q3 Loss per Share $0.17 .
Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial Results.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.